Corpus Intelligence IC Memo — PHYSICIANS CARE SURGICAL HOSPITAL 2026-04-26 09:36 UTC
IC Memo — PHYSICIANS CARE SURGICAL HOSPITAL
Investment Committee Memorandum | PA | 12 beds | Grade D | EBITDA uplift $2.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PHYSICIANS CARE SURGICAL HOSPITAL

CCN 390324 | MONTGOMERY, PA | 12 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PHYSICIANS CARE SURGICAL HOSPITAL is a 12-bed community hospital in MONTGOMERY, PA with $39.9M in net patient revenue and a 16.7% operating margin. The hospital serves a payer mix of 33.1% Medicare, 0.0% Medicaid, and 66.9% commercial.

Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.7% to 24.1% (+736bps).

Net Revenue HCRIS$39.9M
Current EBITDA COMPUTED$6.7M
Operating Margin COMPUTED16.7%
Occupancy HCRIS21.1%
Revenue / Bed COMPUTED$3.3M
Net-to-Gross HCRIS25.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
17
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 16.7% places it above the state median. Among 17 size-comparable peers (6-24 beds), the median margin is -9.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-24), prioritizing same-state peers. 17 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PHYSICIANS CARE SURGICAL HOSPI (Target)PA12$39.9M16.7%
LVH-COORDINATED ALLENTOWNPA20$89.6M2.3%
GOOD SHEPHERD PENN PARTNERSPA18$66.1M-50.0%
ROTHMAN ORTHOPAEDIC SPECIALTY PA24$64.8M20.6%
SURGICAL INSTITUTE OF READINGPA15$58.5M28.1%
MUNCY VALLEY HOSPITALPA20$53.7M-7.7%
FULTON COUNTY MEDICAL CENTERPA21$46.7M-21.3%
TYRONE HOSPITALPA20$25.4M-9.7%
CORRY MEMORIAL HOSPITALPA20$23.9M-20.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$838K+210bp18mo
Cost to Collect4.5%2.5%$798K+200bp12mo
Denial Rate Reduction12.0%6.5%$790K+198bp12mo
A/R Days Reduction5200.0%3800.0%$486K+122bp9mo
Clean Claim Rate88.0%96.0%$26K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$838K
Cost to Collect
$798K
Denial Rate Reduction
$790K
A/R Days Reduction
$486K
Clean Claim Rate
$26K
Total EBITDA Uplift$2.9M
Current EBITDA$6.7M
+ RCM Uplift+$2.9M
Pro Forma EBITDA$9.6M
Current Margin16.7%
Pro Forma Margin24.1%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$10.3M$73.4M7.15x48.2%
Base (11x exit)10.0x11.0x$10.3M$84.1M8.19x52.3%
Bull Case9.0x11.0x$9.2M$97.1M10.51x60.1%
Bull (12x exit)9.0x12.0x$9.2M$108.7M11.76x63.7%
Bear Case11.0x10.0x$11.3M$55.4M4.90x37.4%
Bear (11x exit)11.0x11.0x$11.3M$64.6M5.72x41.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 21.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 17 hospitals with 6-24 beds
  • Same-state prioritization (n=18)
  • Comp margins: P25=-26.4% / P50=-9.7% / P75=4.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.